Overview

A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy Volunteers

Status:
Completed

Trial end date:
2019-06-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the pharmacokinetics and safety/tolerability when administrated fixed dose combination of Fimasartan/Linagliptin and when co-administrated Fimasartan and Linagliptin.

Phase:

Phase 1

Details

Lead Sponsor:

Boryung Pharmaceutical Co., Ltd

Treatments:

Linagliptin